Bayer, Merck Hit With More Suits Over Avelox Nerve Damage

By Dan Packel (July 30, 2015, 5:48 PM EDT) -- At least two new plaintiffs filed complaints Wednesday in Pennsylvania federal court accusing Bayer Corp. and Merck & Co. Inc. of downplaying the risk of permanent nerve damage posed by the antibiotic Avelox and promoting the drug for minor conditions that can be treated with safer medications....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!